Page last updated: 2024-10-21
3-methoxytyramine and Amentia
3-methoxytyramine has been researched along with Amentia in 1 studies
3-methoxytyramine: RN given refers to parent cpd
3-methoxytyramine : A monomethoxybenzene that is dopamine in which the hydroxy group at position 3 is replaced by a methoxy group. It is a metabolite of the neurotransmitter dopamine and considered a potential biomarker of pheochromocytomas and paragangliomas.
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Wester, P | 1 |
Eriksson, S | 1 |
Forsell, A | 1 |
Puu, G | 1 |
Adolfsson, R | 1 |
Other Studies
1 other study available for 3-methoxytyramine and Amentia
Article | Year |
---|---|
Monoamine metabolite concentrations and cholinesterase activities in cerebrospinal fluid of progressive dementia patients: relation to clinical parameters.
Topics: Acetylcholinesterase; Aged; Butyrylcholinesterase; Catecholamines; Cholinesterases; Dementia; Dopami | 1988 |